{"id":"W2620586117","doi":"10.1111/jdv.14377","title":"Impact of ixekizumab treatment on skin‐related personal relationship difficulties in moderate‐to‐severe psoriasis patients: 12‐week results from two Phase 3 trials","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Université Laval; Guenther Dermatology Research Centre","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Psoriasis; Dermatology Life Quality Index; Placebo; Etanercept; Internal medicine; Quality of life (healthcare); Dermatology; Secukinumab; Tumor necrosis factor alpha; Pathology; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008756776,0.00168196,0.004476299,0.0004251848,0.0005724934,0.001617246,0.0009478954,0.002022798,0.003025597],"category_scores_gemma":[0.005642941,0.0006702959,0.006698915,0.0006631741,0.0008499852,0.0009284698,0.0005349672,0.00272572,0.0004964108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000829586,"about_ca_system_score_gemma":0.001425899,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001028519,"about_ca_topic_score_gemma":0.002316244,"domain_scores_codex":[0.9972398,0.001683215,0.0002660493,0.0002686868,0.0002811582,0.0002610789],"domain_scores_gemma":[0.9957324,0.001725088,0.001181113,0.0003951078,0.0003250483,0.0006413832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9030251,0.01303126,0.005063905,0.002946635,0.01083781,0.0000989351,0.0002379163,0.001009831,0.005843031,0.00007954254,0.001768814,0.05605725],"study_design_scores_gemma":[0.809539,0.1577292,0.02374238,0.0002765987,0.005530294,0.0001602901,0.00006317122,0.0005036226,0.0008124197,0.0001714778,0.001418895,0.00005274414],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9640259,0.02596061,0.001382151,0.0009028648,0.0002659408,0.003275095,0.002106721,0.0001742727,0.00190651],"genre_scores_gemma":[0.9776108,0.01004899,0.002435899,0.001158569,0.000358718,0.004362994,0.002262298,0.00004994284,0.001711865],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008756776,"threshold_uncertainty_score":0.04631078,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06330163258511776,"score_gpt":0.3277752161142288,"score_spread":0.2644735835291111,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}